: vimarsana.com

TOKYO -- Japanese pharmaceutical company Eisai plans to further develop lecanemab, the Alzheimer's disease drug that has been approved in the U.S. for

Related Keywords

Japan , Japanese , , Eisai , Enable , Alzheimer S , Drug , Leqembi , Be , Injected , Home ,